menu
    • menu

    Company profile for Shenzhen Chipscreen Biosciences

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CHIPSCREEN BIOSCIENCES was established in March 2001, and is currently a leading enterprise of small molecule innovative medicines in China. CHIPSCREEN BIOSCIENCES puts as the first priority to meet unmet clinical needs. It insists on an “original, safe, excellent and effective China,” and is dedicated in providing patients with affordable innovative mechanisms of therapeutic drugs”. CHIPSCREEN BIOSCIENCES owns headquart...
    CHIPSCREEN BIOSCIENCES was established in March 2001, and is currently a leading enterprise of small molecule innovative medicines in China. CHIPSCREEN BIOSCIENCES puts as the first priority to meet unmet clinical needs. It insists on an “original, safe, excellent and effective China,” and is dedicated in providing patients with affordable innovative mechanisms of therapeutic drugs”. CHIPSCREEN BIOSCIENCES owns headquarters, research and development centers, GMP production bases in Shenzhen and Chengdu, and the Beijing clinical research center and Shanghai commercial center, which is a four-in-one modern biomedicine group company.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shenzhen Chipscreen BiosciencesChina Flag
    Country
    Country
    China
    Address
    Address
    Rooms 601-606, Building 2, Hi-tech Incubator Building, High-tech No. 1 Road, N...
    Telephone
    Telephone
    +86-0755-26957330
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.chipscreen.com/en/index.php/shouye
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Lu Xianping named Chinese mainland winner of the EY Awards
    Dr. Lu Xianping named Chinese mainland winner of the EY Awards

    30 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dr-lu-xianping-founder-chairman-of-chipscreen-biosciences-named-the-chinese-mainland-winner-of-the-ey-entrepreneur-of-the-year-2025-awards-302650394.html

    PR NEWSWIRE
    30 Dec 2025
    Share Share
    Chipscreen's Brain-Penetrant Aurora B Inhibitor Gets IND Approval
    Chipscreen's Brain-Penetrant Aurora B Inhibitor Gets IND Approval

    31 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chipscreen-biosciences-brain-penetrant-aurora-b-selective-inhibitor-cs231295-tablet-receives-fda-ind-approval-advancing-global-clinical-development-302518530.html

    PR NEWSWIRE
    31 Jul 2025
    Share Share
    Phase III Trial for Chiauranib in Small Cell Lung Cancer Approved
    Phase III Trial for Chiauranib in Small Cell Lung Cancer Approved

    01 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-phase-iii-clinical-trial-application-for-first-line-treatment-of-extensive-disease-small-cell-lung-cancer-with-chiauranib-has-been-approved-302294039.html

    PR NEWSWIRE
    01 Nov 2024
    Share Share
    Chipscreen's CS231295 Tablets IND Application Accepted
    Chipscreen's CS231295 Tablets IND Application Accepted

    17 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chipscreen-biosciences-innovative-anti-tumor-drug-cs231295-tablets-investigational-new-drug-ind-application-accepted-302279370.html

    PR NEWSWIRE
    17 Oct 2024
    Share Share
    Chiglitazar Selected For Oral Presentation At Liver Disease Meeting
    Chiglitazar Selected For Oral Presentation At Liver Disease Meeting

    15 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/chiglitazar-for-the-treatment-of-mash-phase-ii-clinical-study-selected-for-oral-presentation-at-the-2024-american-liver-disease-annual-meeting-302276529.html

    PR NEWSWIRE
    15 Oct 2024
    Share Share
    NMPA Approves Chidamide+R-CHOP For Diffuse Large B-Cell Lymphoma
    NMPA Approves Chidamide+R-CHOP For Diffuse Large B-Cell Lymphoma

    30 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/national-medical-products-administration-nmpa-approves-chipscreen-biosciences-chidamide-epidaza-combined-with-r-chop-for-the-treatment-of-diffuse-large-b-cell-lymphoma-302131654.html

    PR NEWSWIRE
    30 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search